Ravi Murthy

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

54h-index10.4kcitations260works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(59), Cancer Immunotherapy and Biomarkers(36), Immunotherapy and Immune Responses(35), Cancer Research and Treatments(31), Retinal Diseases and Treatments(23)

Publications259 total

Abstract C065: Research biopsy participation and safety in cancer therapeutic trials
Molecular Cancer Therapeutics·2025
Supplementary Table S3 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Supplementary Table S2 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Supplementary Figure S1 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Supplementary File S1 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Supplementary Table S1 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Supplementary Figure S2 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Data from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Supplementary Table S4 from Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i>-NT in Patients with Advanced Solid Tumors
2025Open Access
Knowledge, Attitudes, and Practices of Medical Professionals Regarding Cervical Cancer Prevention and Human Papillomavirus (HPV) Vaccination: A Cross-Sectional Study
Cureus·2025Open Access
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i> -NT in Patients with Advanced Solid Tumors
Clinical Cancer Research·2025· 3 citedOpen Access
Chylothorax in Uncommon Contexts: Pulmonary Tuberculosis and Mantle Cell Lymphoma
Respirology Case Reports·2025Open Access
Gastrostomy Tubes in Trauma Patients
Digestive Disease Interventions·2025
Abstract No. 245 Outcomes of Portal and Superior Mesenteric Vein Stenting in Patients with Caner: An Analysis of 250 Stents
Journal of Vascular and Interventional Radiology·2025Open Access
Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics
Immuno-Oncology Technology·2024· 5 citedOpen Access
Abstract No. 315 Software-Based Quantitative Measurement of Drained Liver Volume After Percutaneous Biliary Drain Placement: A Personalized 3D Volumetry Model
Journal of Vascular and Interventional Radiology·2024Open Access
A Sticky Situation: Glue Migration during Hepatic Vein Embolization
Seminars in Interventional Radiology·2023· 3 citedOpen Access
A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 T cells for patients with metastatic uveal melanoma.
Journal of Clinical Oncology·2023· 3 cited
Supplementary Table from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
2023Open Access
Data from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
2023Open Access
page 1 of 13Next →

Frequent Co-authors

David C. Madoff(20), Sanjay Gupta(19), Kamran Ahrar(18), Michael B. Wallace(17), Marshall E. Hicks(16), Riad Salem(12), Frank A. Morello(8), Andrew S. Kennedy(7), Alda L. Tam(7), Robert J. Lewandowski(6), Robert K. Ryu(6), Douglas M. Coldwell(5), James C. Yao(5), Kent T. Sato(5), Bassel Atassi(5), Laura Kulik(5), Reed A. Omary(5), Joe Ensor(5), Charles Nutting(4), David Liu(4)